Overview of the 2022 WHO classification of thyroid neoplasms
This review summarizes the changes in the 5th edition of the WHO Classification of
Endocrine and Neuroendocrine Tumors that relate to the thyroid gland. The new …
Endocrine and Neuroendocrine Tumors that relate to the thyroid gland. The new …
Update on fundamental mechanisms of thyroid cancer
A Prete, P Borges de Souza, S Censi… - Frontiers in …, 2020 - frontiersin.org
The incidence of thyroid cancer (TC) has increased worldwide over the past four decades.
TC is divided into three main histological types: differentiated (papillary and follicular TC) …
TC is divided into three main histological types: differentiated (papillary and follicular TC) …
[HTML][HTML] Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
S Filetti, C Durante, D Hartl, S Leboulleux, LD Locati… - Annals of …, 2019 - Elsevier
This ESMO Clinical Practice Guideline provides updated state-of-the-art recommendations
on management of thyroid cancer (diagnosis, treatment and follow-up), compiled by a …
on management of thyroid cancer (diagnosis, treatment and follow-up), compiled by a …
Introduction, comparison, and validation of Meta‐Essentials: A free and simple tool for meta‐analysis
We present a new tool for meta‐analysis, Meta‐Essentials, which is free of charge and easy
to use. In this paper, we introduce the tool and compare its features to other tools for meta …
to use. In this paper, we introduce the tool and compare its features to other tools for meta …
Risk stratification in differentiated thyroid cancer: from detection to final follow-up
RM Tuttle, AS Alzahrani - The Journal of Clinical Endocrinology …, 2019 - academic.oup.com
Context Modern management of differentiated thyroid cancer requires individualized care
plans that tailor the intensity of therapy and follow-up to the estimated risks of recurrence …
plans that tailor the intensity of therapy and follow-up to the estimated risks of recurrence …
Novel targeted therapies for metastatic thyroid cancer—a comprehensive review
The knowledge on thyroid cancer biology has grown over the past decade. Thus, diagnostic
and therapeutic strategies to manage thyroid cancer are rapidly evolving. With new insights …
and therapeutic strategies to manage thyroid cancer are rapidly evolving. With new insights …
[HTML][HTML] Prevalence of BRAFV600E mutation in Asian series of papillary thyroid carcinoma—a contemporary systematic review
Papillary thyroid carcinoma (PTC), the most common malignancy of the endocrine system, is
frequently driven by BRAF V600E mutation, which was reported in 35–60% cases in …
frequently driven by BRAF V600E mutation, which was reported in 35–60% cases in …
Molecular markers guiding thyroid cancer management
C Nylén, R Mechera, I Maréchal-Ross, V Tsang… - Cancers, 2020 - mdpi.com
The incidence of thyroid cancer is rapidly increasing, mostly due to the overdiagnosis and
overtreatment of differentiated thyroid cancer (TC). The increasing use of potent preclinical …
overtreatment of differentiated thyroid cancer (TC). The increasing use of potent preclinical …
The genetic duet of BRAF V600E and TERT promoter mutations predicts the poor curative effect of radioiodine therapy in papillary thyroid cancer
J Cao, X Zhu, Y Sun, X Li, C Yun, W Zhang - European Journal of Nuclear …, 2022 - Springer
Abstract Objective The BRAF V600E and TERT promoter mutations are well known to be
associated with poor clinical outcomes of papillary thyroid cancer (PTC). Radioactive iodide …
associated with poor clinical outcomes of papillary thyroid cancer (PTC). Radioactive iodide …
The interaction between TERT promoter mutation and MGMT promoter methylation on overall survival of glioma patients: a meta-analysis
Background There are controversial results concerning the prognostic implication of TERT
promoter mutation in glioma patients concerning MGMT status. In this meta-analysis, we …
promoter mutation in glioma patients concerning MGMT status. In this meta-analysis, we …